Select for export The Black Book of Psychotropic Dosing and Monitoring. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64719/pb.4493 PubMed 38993656 Copy citation Copy BibTeX Unknown journal 2024-06-30 DeBattista C, Schatzberg AF. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.63050/jpps.21.02.935 Copy citation Copy BibTeX Journal of Pakistan Psychiatric Society 2024-06-29 Nauman Ashraf OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674241261779 PubMed 38907608 Copy citation Copy BibTeX Australian & New Zealand Journal of Psychiatry 2024-06-21 Zohaib Nadeem, Stephen Parker, Hugh McGovern, Lena Oestreich OpenAlex Published psilocybin Chronic PainObservational StudySafety Observational Study More
Select for export Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.06.17.24308787 Copy citation Copy BibTeX medRxiv 2024-06-19 Fluyau D, Kailasam VK, Revadigar N. medRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export The cyclical revival of psychedelics in psychiatric treatment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/03007995.2024.2368725 PubMed 38880945 Copy citation Copy BibTeX Unknown journal 2024-06-19 Appiani FJ, Caroff SN. Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2024.116018 PubMed 38924903 Copy citation Copy BibTeX Unknown journal 2024-06-19 Guo Q, Guo L, Wang Y, Shang S. Europe PMC Published psilocybin DepressionRandomized Controlled TrialMeta-Analysis Randomized Controlled Trial More
Select for export Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241257839 PubMed 38888164 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-06-17 P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl OpenAlex Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0051 PubMed 40051581 Copy citation Copy BibTeX Unknown journal 2024-06-16 Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J. Europe PMC Published psilocybin AgingClinical TrialReview Article Clinical Trial More
Select for export Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systems Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/add.16589 PubMed 38881433 Copy citation Copy BibTeX Addiction 2024-06-16 P. Todd Korthuis, Adrianne R. Wilson-Poe, Joshua C. Black, Andrew A. Monte OpenAlex Published psilocybin AddictionMechanism of ActionAging Clinical Trial More
Select for export Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241254831 PubMed 38877715 Copy citation Copy BibTeX Unknown journal 2024-06-13 Polito V, Liknaitzky P. Europe PMC Published psilocybin MicrodosingRandomized Controlled TrialReview Article Randomized Controlled Trial More
Select for export Psychedelics’ Use as Medicine Hits Significant Roadblock Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.07.7.54 Copy citation Copy BibTeX Psychiatric News 2024-06-11 Linda M. Richmond OpenAlex Published psilocybin DepressionPTSDPharmacology Clinical Trial More
Select for export Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1406888 PubMed 38919636 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-06-10 Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz OpenAlex Published psilocybin DepressionAddictionOCD Clinical Trial More
Select for export Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/adnpg Copy citation Copy BibTeX PsyArXiv 2024-06-09 Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK. PsyArXiv PREPRINT (not peer reviewed) psilocybin AddictionClinical TrialHealthcare Workers Clinical Trial More
Select for export A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-06-09 University of Sydney ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-06-09 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionPharmacology Clinical Trial More
Select for export Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/um2cy Copy citation Copy BibTeX PsyArXiv 2024-06-06 Calder A, Hasler G. PsyArXiv PREPRINT (not peer reviewed) psilocybin SafetyAdverse Events Other More
Select for export Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-06-06 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin SafetyAdverse Events Other More
Select for export Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/bph.16466 PubMed 38825326 Copy citation Copy BibTeX British Journal of Pharmacology 2024-06-01 Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, Oscar Sandoval, Hunter G. Wells, Quynh Nguyen OpenAlex Published psilocybinpsilocin Brain ImagingPharmacologyReceptor Pharmacology In Vitro Study More
Select for export Therapeutic Implications of Psilocybin in the Wake of Decriminalization Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/ict.2024.27206.nl Copy citation Copy BibTeX Integrative and Complementary Therapies 2024-05-31 Nikola Lash, George Tadros, Eman Tadros OpenAlex Published psilocybin AddictionSafety Other More
Select for export Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2023.4685 PubMed 38055270 Copy citation Copy BibTeX Unknown journal 2024-05-31 Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A Europe PMC Published psilocybin DepressionSafety Clinical Trial More